Cas 24728-07-2,3,4-dibromo-5-methyl-pyrrole-2-carboxylic acid ethyl ester

24728-07-2

Post Buying Request

Basic information

Product Name: 3,4-dibromo-5-methyl-pyrrole-2-carboxylic acid ethyl ester
Synonyms: 3,4-dibromo-5-methyl-pyrrole-2-carboxylic acid ethyl ester
CAS NO:24728-07-2
Molecular Formula:
Molecular Weight: 310.973
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: 369.2±37.0 °C(Predicted)
Flash Point: N/A
Appearance: N/A
Density: 1.820±0.06 g/cm3(Predicted)
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3,4-dibromo-5-methyl-pyrrole-2-carboxylic acid ethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 3,4-dibromo-5-methyl-pyrrole-2-carboxylic acid ethyl ester(24728-07-2)
EPA Substance Registry System: 3,4-dibromo-5-methyl-pyrrole-2-carboxylic acid ethyl ester(24728-07-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 24728-07-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

24728-07-2 Suppliers

Recommended suppliers

24728-07-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 24728-07-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,7,2 and 8 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 24728-07:
(7*2)+(6*4)+(5*7)+(4*2)+(3*8)+(2*0)+(1*7)=112
112 % 10 = 2
So 24728-07-2 is a valid CAS Registry Number.

24728-07-2Upstream product

3284-51-3 ethyl 5-methyl-1H-pyrrole-2-carboxylate

24728-07-2Downstream Products

3651-12-5 5-methyl-3,4-diphenyl-1H-pyrrole-2-carboxylic acid ethyl ester

24728-07-2Relevant academic research and scientific papers

2-(PIPERIDIN-1-YL)-4-AZOLYL-THIAZOLE-5-CARBOXYLIC ACID DERIVATIVES AGAINST BACTERIAL INFECTIONS

-

Page/Page column 71, (2010/07/02)

Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 24728-07-2